Johnson & Johnson was founded over 125 years ago in the year 1886. However, it wasn't until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in ...

Conrad Wilson is a reporter and producer covering criminal justice and legal affairs for OPB. Prior to coming to OPB, he was a reporter at Minnesota Public Radio. Before that he ran the news ...

Speaker Mike Johnson (R-La.) is disputing Democrats’ assertion that he wants to repeal ObamaCare after Vice President Harris’s campaign seized on comments he made at a campaign stop this week.

Mike Johnson qualifies answer about accepting a potential Kamala Harris victory ...

Magic Johnson and his second child, EJ, are the “most alike” out of anyone in their family JC Olivera/WireImage/Getty Images Magic Johnson often shares that his son, EJ Johnson, changed who he is.

Johnson later said his objection to the CHIPS Act was related to other programs that were included in the bill. “We’re going to support chip manufacturing, we do not support the Green New Deal.

Washington — House Speaker Mike Johnson diverted Sunday on questions about possible violence and security concerns ahead of the certification of the presidential election results early next year ...

Johnson & Johnson stock (NYSE: JNJ) will report its Q3 2024 results on Tuesday, October 15. We expect the company to post revenue of $22.2 billion and earnings of $2.20 per share, broadly aligning ...

House Speaker Mike Johnson ripped CBS News for trimming down his Sunday interview on “Face the Nation,” charging it was part of a pattern of undermining conservatives at the Tiffany Network.

The Panthers will send Diontae Johnson and a sixth round pick north to the Baltimore Ravens in exchange for a fifth-rounder in the 2025 NFL Draft. It’s a deal that helps boost Carolina’s ...

Johnson Controls was named the overall leader for its Smart Building Management Platform in the Smart Building Management Platforms assessment, conducted by ABI Research, a global technology ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...